Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 69
- Companies
Flora investment in Hoshi paves way for European cannabis distribution
The move will see Flora’s finished cannabis products reach patients in Europe.
- Companies
German and Colombian cannabis markets driving Khiron sales growth
Khiron has expanded its product offerings in both the UK and Germany.
- Medical
Grow group: innovating cannabis medicines and improving access
Grow Group co-founder and CEO Ben Langley spoke about the company’s aims, cannabis innovation and its plans for expansion.
- Pharmaceutical
Oxford Cannabinoid Technologies applies for admission to OTC QB Market
Oxford Cannabinoid Technologies has applied to be admitted to the OTC QB Market in the United States.
- Cultivation
Cannabis genetics to be developed for specific healthcare applications
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
- Cultivation
Could new trichome structure revolutionise cannabis production?
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
- CBD Market
Award-winning Vitality CBD acquired by Yooma Wellness
This is the first acquisition made since Yooma completed its dual-listing on the AQSE Growth Market in London.
- Uncategorized
Lidl signs million dollar deal to sell cannabis products
The hemp products will not contain any THC or CBD.
- Medical
Panaxia and Neuraxpharm to bring medical cannabis products to Poland
The exclusive agreement will enable the distribution of Panaxia’s advanced medical cannabis products in Poland.
- Medical
Flowr and Cookies to bring ultra-premium medical cannabis strains to EU
Flowr will be growing some of the most recognisable cannabis strains in the world, including Gelatti and Pink Runtz, in Portugal.
- Companies
Tilray acquires MedMen stake in move towards US cannabis market
Tilray says the move will facilitate a path to the US cannabis market.
- Medical
Materia enters agreement with Eurox for cannabis extract distribution
Extracts are currently the fastest growing product in the German medical cannabis market.
